Bio-Path Holdings, Inc.
BPTH
$0.03
$0.0171.33%
OTC PK
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -77.22% | 531.71% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 215.49% | 624.39% | |||
| Operating Income | -215.49% | -624.39% | |||
| Income Before Tax | -876.30% | -8.43% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -876.30% | -8.43% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -876.30% | -8.43% | |||
| EBIT | -215.49% | -624.39% | |||
| EBITDA | -219.70% | -610.49% | |||
| EPS Basic | -202.77% | 8.25% | |||
| Normalized Basic EPS | -44.81% | -12.27% | |||
| EPS Diluted | -202.77% | 8.25% | |||
| Normalized Diluted EPS | -44.81% | -12.27% | |||
| Average Basic Shares Outstanding | 222.54% | 18.16% | |||
| Average Diluted Shares Outstanding | 222.54% | 18.16% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||